GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (SHSE:600671) » Definitions » Scaled Net Operating Assets

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Scaled Net Operating Assets : -0.04 (As of Sep. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's operating assets for the quarter that ended in Sep. 2023 was ¥239.5 Mil. Hangzhou TianMuShan Pharmaceutical Enterprise Co's operating liabilities for the quarter that ended in Sep. 2023 was ¥250.0 Mil. Hangzhou TianMuShan Pharmaceutical Enterprise Co's Total Assets for the quarter that ended in Jun. 2023 was ¥256.6 Mil. Therefore, Hangzhou TianMuShan Pharmaceutical Enterprise Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was -0.04.


Hangzhou TianMuShan Pharmaceutical Enterprise Co Scaled Net Operating Assets Historical Data

The historical data trend for Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Scaled Net Operating Assets Chart

Hangzhou TianMuShan Pharmaceutical Enterprise Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.41 0.40 0.34 0.19

Hangzhou TianMuShan Pharmaceutical Enterprise Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.22 0.28 0.31 -0.04

Competitive Comparison of Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets falls into.



Hangzhou TianMuShan Pharmaceutical Enterprise Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2022 )
=(Operating Assets (A: Dec. 2022 )-Operating Liabilities (A: Dec. 2022 ))/Total Assets (A: Dec. 2021 )
=(257.448-179.356)/402.649
=0.19

where

Operating Assets(A: Dec. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=299.84 - 42.392
=257.448

Operating Liabilities(A: Dec. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=295.36 - 7.463 - 108.541
=179.356

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2023 )
=(Operating Assets (Q: Sep. 2023 )-Operating Liabilities (Q: Sep. 2023 ))/Total Assets (Q: Jun. 2023 )
=(239.497-250.049)/256.606
=-0.04

where

Operating Assets(Q: Sep. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=340.443 - 100.946
=239.497

Operating Liabilities(Q: Sep. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=362.804 - 6.656 - 106.099
=250.049

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou TianMuShan Pharmaceutical Enterprise Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Hangzhou TianMuShan Pharmaceutical Enterprise Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Business Description

Traded in Other Exchanges
N/A
Address
No.18 Shangyang Road, Jinnan Street, Lin'an District, Zhejiang Province, Hangzhou, CHN, 311300
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China. The company is also engaged in medical device production and sales, cosmetics production, sales, production and sales of sanitary products.

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Headlines

No Headlines